Oskar Vilhelmsson Timmermand

affiliated with the university
More filtering options
  1. 2019
  2. Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics

    Oskar Vilhelmsson Timmermand, Elgqvist, J., Beattie, K. A., Anders Örbom, Erik Larsson, Sophie E Eriksson, Thorek, D. L. J., Beattie, B. J., Thuy A Tran, David Ulmert & Sven-Erik Strand, 2019, In : Theranostics. 9, 8, p. 2129-2142 14 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

    McDevitt, M. R., Thorek, D. L. J., Hashimoto, T., Gondo, T., Veach, D. R., Sharma, S. K., Kalidindi, T. M., Abou, D. S., Watson, P. A., Beattie, B. J., Oskar Vilhemsson Timmermand, Sven Erik Strand, Lewis, J. S., Scardino, P. T., Scher, H. I., Hans Lilja, Larson, S. M. & David Ulmert, 2018 Dec 1, In : Nature Communications. 9, 1, 1629.

    Research output: Contribution to journalArticle

  5. 2016
  6. 2015
  7. Diffuse reflectance spectroscopy of liver tissue

    Nina Reistad, Jan Nilsson, Oskar Vilhelmsson Timmermand, Sturesson, C. & Andersson-Engels, S., 2015, [Host publication title missing]. SPIE, Vol. 9531. p. 95314E 10 p.

    Research output: Chapter in Book/Report/Conference proceedingPaper in conference proceeding

  8. 2014
  9. Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a In-111-radiolabelled monoclonal antibody, 11B6

    Oskar Vilhelmsson Timmermand, Ulmert, D., Evans-Axelsson, S., Pettersson, K., Bjartell, A., Lilja, H., Sven-Erik Strand & Thuy Tran, 2014, In : EJNMMI Research. 4, 51.

    Research output: Contribution to journalArticle

  10. Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer Preclinical evaluation of kallikrein related peptidase 2 targeting

    Oskar Vilhelmsson Timmermand, 2014, Department of Medical Radiation Physics, Clinical Sciences, Lund, Lund University. 118 p.

    Research output: ThesisDoctoral Thesis (monograph)